D. E. Shaw & Co., Inc. Dexcom Inc Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Dexcom Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,081,769 shares of DXCM stock, worth $264 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,081,769

Previous 20,000 15308.85%

Holding current value

$264 Million

Previous $1.56 Million 13434.02%

% of portfolio

0.21%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$67.74 - $90.75 $30.4 Million - $40.7 Million	-448,364 Reduced 12.7%	3,081,769 $210 Million
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $72.3 Million - $89.2 Million	1,100,610 Added 45.3%	3,530,133 $275 Million
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $153 Million - $278 Million	2,393,783 Added 6697.77%	2,429,523 $163 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $54.6 Million - $69.6 Million	-495,211 Reduced 93.27%	35,740 $4.05 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $46.2 Million - $56.7 Million	404,440 Added 319.69%	530,951 $73.6 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $2.69 Million - $4.42 Million	-35,617 Reduced 21.97%	126,511 $15.7 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $10.4 Million - $16.6 Million	-120,448 Reduced 42.62%	162,128 $15.1 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $14 Million - $16.3 Million	124,523 Added 78.79%	282,576 $36.3 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $10.2 Million - $12.1 Million	98,408 Added 164.99%	158,053 $18.4 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $4.75 Million - $6.86 Million	55,884 Added 1485.88%	59,645 $6.75 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $7,864 - $9,700	103 Added 2.82%	3,761 $303,000
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $230,894 - $451,294	-3,396 Reduced 48.14%	3,658 $273,000
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $908,624 - $1.26 Million	-9,658 Reduced 57.79%	7,054 $3.61 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $4.29 Million - $5.37 Million	-33,006 Reduced 66.39%	16,712 $8.97 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $1.85 Million - $2.48 Million	17,354 Added 53.62%	49,718 $27.2 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $740,815 - $987,235	9,147 Added 39.4%	32,364 $13.8 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $1.29 Million - $1.6 Million	15,257 Added 191.67%	23,217 $8.34 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $3.46 Million - $4.64 Million	-44,380 Reduced 84.79%	7,960 $2.94 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $3.51 Million - $4.16 Million	36,797 Added 236.74%	52,340 $21.6 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $37.1 Million - $62.4 Million	-592,360 Reduced 97.44%	15,543 $6.3 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $12.8 Million - $20.2 Million	266,872 Added 78.25%	607,903 $164 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $12.1 Million - $18.9 Million	330,549 Added 3153.49%	341,031 $74.6 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $3.15 Million - $3.88 Million	-88,525 Reduced 89.41%	10,482 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $12.2 Million - $17.1 Million	-438,751 Reduced 81.59%	99,007 $14.8 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $3.96 Million - $5.39 Million	-141,124 Reduced 20.79%	537,758 $64 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $9.51 Million - $13.2 Million	352,345 Added 107.9%	678,882 $81.3 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $2.48 Million - $3.91 Million	106,377 Added 48.32%	326,537 $46.7 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $3.86 Million - $5.55 Million	220,160 New	220,160 $20.9 Million

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account